Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Lung Cancer: Targets and Therapy
Volume 14, 2023 - Issue
PERSPECTIVES
ALESIA 5-Year Update: Alectinib at 600 mg Twice Daily Gives Lorlatinib a Run for Its Money in Asia
Alexandria TM Lee1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA
https://orcid.org/0000-0002-2618-8131
https://orcid.org/0000-0002-2618-8131 & Saihong Ignatius Ou1 Department of Medicine, University of California Irvine School of Medicine, Orange, CA, USA;2 Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-1764-4975
https://orcid.org/0000-0002-1764-4975